Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

82. Parkinsons Foundation 2017 Annual Report. Parkinson’s Foundation; 2017.

83. Impact of the Ice Bucket Challenge. ALS Association. www.alsa.org/ fight-als/ibc-infographic.html. Accessed February 8, 2019.

84. ACT UP New York. www.actupny.org. Accessed March 30, 2019.

85. ParkinsonNet. www.parkinsonnet.info. Accessed January 5, 2019.

86. Okun MS, Ramirez-Zamora A, Foote KD. Neuromedicine service and science hub model. JAMA Neurology. 2018;75(3):271–272.

87. Bloem BR, Rompen L, de Vries NM, Klink A, Munneke M, Jeurissen P. ParkinsonNet: a low-cost health care innovation with a systems approach from the Netherlands. Health Affairs. 2017;36:1987–1996.

88. van der Kolk NM, de Vries NM, Penko AL, et al. A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson’s disease: results of a small randomised feasibility trial. Journal of Neurology, Neurosurgery & Psychiatry. 2018;89(9):1003.

89. Szanton SL, Leff B, Wolff JL, Roberts L, Gitlin LN. Home-based care program reduces disability and promotes aging in place. Health Affairs. 2016;35(9):1558–1563.

90. Buchanan RJ, Wang S, Huang C, Simpson P, Manyam BV. Analyses of nursing home residents with Parkinson’s disease using the minimum data set. Parkinsonism & Related Disorders.

2002;8(5):369–380; Ornstein KA, Leff B, Covinsky KE, et al. Epidemiology of the homebound population in the United States. JAMA Internal Medicine. 2015;175(7):1180–1186; Mitchell SL, Kiely DK, Kiel DP, Lipsitz LA. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson’s disease. Journal of the American Geriatrics Society. 1996;44(4):394–399.

91. Centers for Medicare & Medicaid Services. Medicare & Home Health Care. US Department of Health and Human Services. October 2017. www.medicare.gov/sites/default/files/2018-07/10969-medicare-and-home-health-care.pdf; Your Medicare coverage. Medicare.gov. www. medicare.gov/coverage/home-health-services. Accessed March 30, 2019.

92. Woods B. By 2020, 90 % of world’s population aged over 6 will have a mobile phone: report. The Next Web. November 18, 2014. https:// thenextweb.com/insider/2014/11/18/2020-90-worlds-population-aged-6-will-mobile-phone-report. Accessed October 11, 2018.

93. Dorsey ER, Glidden AM, Holloway MR, Birbeck GL, Schwamm LH. Teleneurology and mobile technologies: the future of neurological care. Nature Reviews Neurology. 2018;14:285–297.

94. WHO Model List of Essential Medicines. World Health Organization; April 2015.

95. Clinical trial delays: America’s patient recruitment dilemma. Drug Development Technology. July 18, 2012. www.drugdevelopment-technology.com/features/featureclinical-trial-patient-recruitment. Accessed March 30, 2019.

96. Fox Trial Finder. The Michael J. Fox Foundation for Parkinson’s Research. https://foxtrialfinder.michaeljfox.org. Accessed March 30, 2019.

97. Why Clinical Trials? The Michael J. Fox Foundation for Parkinson’s Research.https://files.michaeljfox.org/WhyClinicalTrials.pdf. Accessed January 3, 2019; Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, Tilley BC. Minority enrollment in Parkinson’s disease clinical trials. Parkinsonism & Related Disorders.

2009;15(4):258–262.

98. Bot BM, Suver C, Neto EC, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Scientific Data. 2016;3:160011.

99. Fox Insight. The Michael J. Fox Foundation for Parkinson’s Research. https://foxinsight.michaeljfox.org. Accessed January 6, 2019.

100. Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson’s disease. Movement Disorders. 2015;30(12):1600–1611.

101. P earson SD, Rawlins MD. Quality, innovation, and value for money: NICE and the British National Health Service. JAMA. 2005;294(20):2618–2622.

102. Weintraub A. How to cover Novartis’ $475K CAR-T drug Kymriah? A “new payment model” is the only way, Express Scripts says. FiercePharma. September 22, 2017. www.fiercepharma.com/financials/ car-t-and-other-gene-therapies-need-new-payment-model-says-express-scripts. Accessed January 6, 2019; Rosenblatt M, Termeer H. Reframing the conversation on drug pricing. NEJM Catalyst. November 20, 2017. https://catalyst.nejm.org/reframing-conversation-drug-pricing. Accessed June 28, 2019.